Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bruchelt

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Medical and Pediatric Oncology|December 7, 2000
6-fluorodopamine selectively destroys neuroblastoma cells expressing the noradrenaline transporterG Seitz, G Bruchelt, Z Kuci, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1989
Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cellsR Handgretinger, A Kimmig, P Lang, et al.
Bone Marrow Transplantation|April 1, 1987
Kinetics of restoration of interferon production after bone marrow transplantation in manE Koscielniak, G Bruchelt, J Treuner, et al.
Cancer|June 15, 1996
Control of neuroblastoma cell proliferation and differentiation by human bone marrowT Hahn, R Or, G Bruchelt, et al.
Progress in Clinical and Biological Research|January 1, 1991
Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidineT Klingebiel, G Bruchelt, N Kaleva, et al.
Journal of Interferon Research|February 1, 1990
In vitro and in vivo effect of interleukin-2 on the 2',5'-oligoadenylate synthetase activity of peripheral mononuclear blood cellsR Handgretinger, G Bruchelt, A Kimmig, et al.
Progress in Clinical and Biological Research|January 1, 1991
The interferon induced 2-5A system in neuroblastomaG Bruchelt, K Schilbach, R Handgretinger, et al.
Cancer Genetics and Cytogenetics|February 25, 2000
SiMa, a new neuroblastoma cell line combining poor prognostic cytogenetic markers with high adrenergic differentiationP Marini, R A MacLeod, C Treuner, et al.
Klinische Padiatrie|July 1, 1990
[The role of interferons in neuroblastoma. 2: Immunomodulatory effects]R Handgretinger, G Bruchelt, B Daurer, et al.
Immunology Letters|September 1, 1989
Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donorsG Bruchelt, R Handgretinger, G Fierlbeck, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Medical and Pediatric Oncology|December 7, 2000
6-fluorodopamine selectively destroys neuroblastoma cells expressing the noradrenaline transporterG Seitz, G Bruchelt, Z Kuci, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1989
Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cellsR Handgretinger, A Kimmig, P Lang, et al.
Bone Marrow Transplantation|April 1, 1987
Kinetics of restoration of interferon production after bone marrow transplantation in manE Koscielniak, G Bruchelt, J Treuner, et al.
Cancer|June 15, 1996
Control of neuroblastoma cell proliferation and differentiation by human bone marrowT Hahn, R Or, G Bruchelt, et al.
Progress in Clinical and Biological Research|January 1, 1991
Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidineT Klingebiel, G Bruchelt, N Kaleva, et al.
Journal of Interferon Research|February 1, 1990
In vitro and in vivo effect of interleukin-2 on the 2',5'-oligoadenylate synthetase activity of peripheral mononuclear blood cellsR Handgretinger, G Bruchelt, A Kimmig, et al.
Progress in Clinical and Biological Research|January 1, 1991
The interferon induced 2-5A system in neuroblastomaG Bruchelt, K Schilbach, R Handgretinger, et al.
Cancer Genetics and Cytogenetics|February 25, 2000
SiMa, a new neuroblastoma cell line combining poor prognostic cytogenetic markers with high adrenergic differentiationP Marini, R A MacLeod, C Treuner, et al.
Klinische Padiatrie|July 1, 1990
[The role of interferons in neuroblastoma. 2: Immunomodulatory effects]R Handgretinger, G Bruchelt, B Daurer, et al.
Immunology Letters|September 1, 1989
Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donorsG Bruchelt, R Handgretinger, G Fierlbeck, et al.
Pageof 9